Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
48.74
+2.39 (5.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.
The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.
The company’s products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations.
Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Pro-Dex, Inc.
| Country | United States |
| Founded | 1978 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 148 |
| CEO | Richard Van Kirk |
Contact Details
Address: 2361 McGaw Avenue Irvine, California 92614 United States | |
| Phone | 949 769 3200 |
| Website | pro-dex.com |
Stock Details
| Ticker Symbol | PDEX |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000788920 |
| CUSIP Number | 74265M205 |
| ISIN Number | US74265M2052 |
| Employer ID | 84-1261240 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Richard Lee Van Kirk Jr. | Chief Executive Officer, President and Director |
| Alisha K. Charlton | Chief Financial Officer and Corporate Secretary |
| Chris Jackson | Directors of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 25, 2024 | 8-K | Current Report |
| Nov 22, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 10-Q | Quarterly Report |
| Oct 25, 2024 | 8-K | Current Report |
| Oct 8, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 8, 2024 | DEF 14A | Other definitive proxy statements |
| Sep 5, 2024 | 8-K | Current Report |
| Sep 5, 2024 | 10-K | Annual Report |
| Aug 9, 2024 | 8-K | Current Report |